What is the patient acquisition cost for an eye hospital in India?
There's no single honest answer, because an ophthalmology practice runs two separate acquisition economies under one roof. Cataract volume is scheme-funded and referral-driven, so paid acquisition barely touches it. Refractive surgery (LASIK and similar) is elective, cash-pay, and entirely dependent on marketing, which is where acquisition cost genuinely determines profitability. no published specialty benchmark exists; see CPQL benchmarks for national average methodology Against the specialty-agnostic national average, cost per qualified lead runs near 2,750 rupees, typically falling 38 to 58 percent within 90 days of proper campaign instrumentation.
Two patients, two sets of unit economics
A cataract patient often arrives through a referring GP, an empanelled scheme, or word of mouth from a previous patient. Acquisition cost here is close to invisible on a paid-media dashboard, because the channel doing the work isn't a channel a media report can see. A refractive-surgery patient behaves like any other high-consideration, cash-pay buyer: researching for weeks, comparing three or four clinics, reading reviews before booking a consult. That patient is acquired the same way a cosmetic-dermatology or hair-transplant patient is acquired, through sustained paid search and social presence, and the cost per enquiry reflects that.
Reporting one blended CPQL across both patient types produces a number that undersells refractive acquisition cost and overstates cataract's, and a hospital that budgets against the blend usually under-invests in the one line where marketing spend actually drives revenue.
What an acceptable acquisition cost looks like against procedure value
Refractive surgery in India runs from roughly 25,000 to 1.2 lakh per eye depending on the technique and the city, so the acquisition cost needs to sit at a small fraction of that ticket to make sense. A clinic paying 3,000 to 5,000 rupees per qualified refractive enquiry, with a healthy consult-to-surgery conversion rate, is typically well inside a defensible cost-to-value ratio. Cataract, by contrast, should mostly be judged on referral-network health and reputation metrics rather than a paid-acquisition dashboard, since that's not where the volume originates.
How conversion actually plays out
A qualified enquiry isn't a booked surgery. Refractive leads go through a consultation, sometimes a second opinion, and a scheduling step before the procedure happens, and each stage loses some percentage of the funnel. Cataract enquiries, where they do arrive through paid channels at all, tend to convert faster because the clinical need is already established by a referring doctor. Tracking these two funnels separately, rather than one combined "patient acquisition cost," is the only way to know which spend is actually earning its keep.
Frequently asked questions
Why can't ophthalmology have one patient acquisition cost figure like other specialties? Because cataract and refractive surgery sit on genuinely different acquisition paths inside the same practice. Cataract is referral- and scheme-driven; refractive surgery is paid-acquisition-driven. Averaging the two produces a figure that doesn't describe either accurately.
Is LASIK marketing spend worth it if cataract volume is already strong? Usually yes, on its own merits, since refractive surgery is the one revenue line in ophthalmology where marketing spend has a direct, measurable effect on volume. Strong cataract referrals don't substitute for that.
What's a reasonable cost per qualified refractive-surgery enquiry? Most well-run campaigns land in the 3,000 to 5,000 rupee range per qualified enquiry, though this shifts with city, competitive density and how tightly the funnel is instrumented.
Does cataract acquisition cost matter at all for budgeting? It matters for measuring referral-network health and reputation systems, not for a paid-media dashboard. A hospital tracking only paid-channel CPQL will miss most of what actually drives cataract volume.
How does this connect to overall ophthalmology marketing budgeting? Acquisition cost tells a practice what its spend is buying; marketing cost tells it what it's spending in the first place. See the ophthalmology marketing cost breakdown for the budget-allocation side of this question.
Author: Raman Soni · Reviewed by Abhash Kumar, Co-Founder, Strategy
See structured CPQL benchmarks across specialties at cpql-benchmarks-india, how ICG works with eye hospitals at industries/ophthalmology, and ICG's ophthalmology marketing agency offering. Get a free audit or book a call to model your own refractive-surgery acquisition funnel.
Detailed answers
Running the numbers for your practice?
Book a free CPQL and budget diagnostic for ophthalmology.
Raman Soni walks through what your acquisition cost looks like against ICG's live benchmarks, where your budget is over- or under-invested, and what a realistic 90-day CPQL target is for your practice.
More from
the ICG Q&A library.
What does healthcare marketing cost in India in 2026?
What is CPQL and how is it different from CPL in healthcare marketing?
How much do Google Ads cost for doctors in India?
What is NMC-compliant marketing for doctors in India?
What is a good CPQL benchmark for Indian healthcare in 2026?
How do healthcare clinics in India use WhatsApp Business API?